PEN Penumbra Inc

Price (delayed)

$240.54

Market cap

$8.78B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.16

Enterprise value

$8.8B

Sector: Healthcare
Industry: Medical Devices

Highlights

PEN's equity is up by 34% year-on-year and by 2.1% since the previous quarter
PEN's revenue is up by 6% year-on-year and by 6% since the previous quarter
The net income has plunged by 114% YoY but it has soared by 66% from the previous quarter
PEN's EPS has shrunk by 114% YoY but it has soared by 64% QoQ
Penumbra's gross margin has decreased by 10% YoY

Key stats

What are the main financial stats of PEN
Market
Shares outstanding
36.48M
Market cap
$8.78B
Enterprise value
$8.8B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
13.38
Price to sales (P/S)
14.81
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
14.85
Earnings
Revenue
$592.29M
EBIT
-$20.88M
EBITDA
-$7.47M
Free cash flow
-$60.31M
Per share
EPS
-$0.16
Free cash flow per share
-$1.65
Book value per share
$17.97
Revenue per share
$16.25
TBVPS
$22.57
Balance sheet
Total assets
$840.82M
Total liabilities
$190.35M
Debt
$76.78M
Equity
$655.09M
Working capital
$523.27M
Liquidity
Debt to equity
0.12
Current ratio
5.68
Quick ratio
3.3
Net debt/EBITDA
-2.83
Margins
EBITDA margin
-1.3%
Gross margin
61%
Net margin
-0.9%
Operating margin
-4.4%
Efficiency
Return on assets
-0.7%
Return on equity
-0.8%
Return on invested capital
-3%
Return on capital employed
-2.9%
Return on sales
-3.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PEN stock price

How has the Penumbra stock price performed over time
Intraday
-0.11%
1 week
-11.38%
1 month
-13.55%
1 year
42.29%
YTD
37.45%
QTD
-11.1%

Financial performance

How have Penumbra's revenue and profit performed over time
Revenue
$592.29M
Gross profit
$361.5M
Operating income
-$26.09M
Net income
-$5.29M
Gross margin
61%
Net margin
-0.9%
Penumbra's operating income has shrunk by 171% YoY but it has increased by 33% QoQ
PEN's operating margin has plunged by 167% YoY but it is up by 36% from the previous quarter
The net income has plunged by 114% YoY but it has soared by 66% from the previous quarter
Penumbra's net margin has shrunk by 113% YoY but it has surged by 68% QoQ

Growth

What is Penumbra's growth rate over time

Valuation

What is Penumbra stock price valuation
P/E
N/A
P/B
13.38
P/S
14.81
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
14.85
PEN's EPS has shrunk by 114% YoY but it has soared by 64% QoQ
PEN's equity is up by 34% year-on-year and by 2.1% since the previous quarter
The stock's P/B is 33% above its 5-year quarterly average of 10.1 and 16% above its last 4 quarters average of 11.6
PEN's price to sales (P/S) is 40% higher than its 5-year quarterly average of 10.6 and 12% higher than its last 4 quarters average of 13.2
PEN's revenue is up by 6% year-on-year and by 6% since the previous quarter

Efficiency

How efficient is Penumbra business performance
PEN's ROS has shrunk by 149% YoY but it is up by 43% QoQ
The company's return on invested capital has shrunk by 138% YoY but it rose by 44% QoQ
The ROA has plunged by 111% YoY but it has soared by 65% from the previous quarter
The ROE has plunged by 110% YoY but it has soared by 69% from the previous quarter

Dividends

What is PEN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PEN.

Financial health

How did Penumbra financials performed over time
Penumbra's total assets has increased by 27% YoY and by 2.2% from the previous quarter
Penumbra's current ratio has increased by 10% YoY but it has decreased by 2.6% from the previous quarter
Penumbra's debt is 88% lower than its equity
PEN's equity is up by 34% year-on-year and by 2.1% since the previous quarter
PEN's debt to equity is down by 25% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.